drugset / Trial / NCT00409032
A Dose-response Study With Strontium Malonate in Postmenopausal Women
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of the study is to compare dose-response effect of three dose levels of strontium malonate to placebo on bone resorption quantified by S-CTX-1 following 12 weeks of treatment.
Timeline
- Start
- 2006-12
- Primary completion
- 2007-08
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Strontium malonate | Unknown | 750 mg | — |
| Subject | Strontium malonate | Unknown | 1000 mg | — |
| Subject | Strontium malonate | Unknown | 2000 mg | — |